Healthcare Technology Report September 9, 2024

HistoSonics, a leading developer of non-invasive histotripsy therapy platforms, has announced the completion of a $102 million Series D financing round, significantly oversubscribed and led by Alpha Wave Ventures. The round saw participation from new investors, including Amzak Health and HealthQuest Capital, along with existing backers such as Johnson & Johnson Innovation – JJDC, and Lumira Ventures.

The funds will be utilized...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Investments, Medical Devices, Trends
Related Articles:
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article